Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$6.56 - $10.95 $1.48 Million - $2.47 Million
-225,618 Reduced 66.05%
115,962 $794,000
Q2 2023

Aug 14, 2023

BUY
$7.89 - $10.64 $1.76 Million - $2.38 Million
223,656 Added 189.66%
341,580 $3.54 Million
Q1 2023

May 15, 2023

SELL
$7.07 - $17.95 $2.13 Million - $5.41 Million
-301,160 Reduced 71.86%
117,924 $954,000
Q4 2022

Feb 14, 2023

BUY
$14.33 - $18.37 $2.14 Million - $2.74 Million
149,136 Added 55.25%
419,084 $6.6 Million
Q3 2022

Nov 14, 2022

BUY
$13.07 - $18.22 $3.53 Million - $4.92 Million
269,948 New
269,948 $4.25 Million
Q1 2022

May 16, 2022

SELL
$9.74 - $17.92 $100,721 - $185,310
-10,341 Closed
0 $0
Q4 2021

Mar 03, 2022

BUY
$12.27 - $18.49 $126,884 - $191,205
10,341 New
10,341 $150,000
Q3 2019

Nov 14, 2019

SELL
$0.79 - $2.47 $43,450 - $135,850
-55,000 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$2.13 - $7.06 $117,150 - $388,300
55,000 New
55,000 $120,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $255M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.